Nanolive: Funding, Investors & Team (Sep 2026)
Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).
Nanolive has raised $22.2M across 2 funding rounds on record, the most recent a Series C of $2.2M announced in Sep 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nanolive Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Nanolive Funding Rounds
Nanolive raised $20.0M in a Series C announced in Apr 2022.
5 months later, a Series C of $2.2M was announced in Sep 2022.
Nanolive Founders and Leadership Team
Contact details for the Nanolive team: 1 of 1 has an email address on file.
Start 14-day free trial →Nanolive Funding Compared to Other Biotechnology Startups
Nanolive's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nanolive in Biotechnology and Ecublens
Companies Similar to Nanolive
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Nanolive Funding FAQs
What does Nanolive do?
Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).
How much funding has Nanolive raised?
Nanolive has raised $22.2M across 2 rounds on record. The most recent is a Series C of $2.2M announced in Sep 2022.
When did Nanolive last raise funding?
Nanolive's most recent funding round on record is a Series C of $2.2M, announced in Sep 2022.
Who is the CEO of Nanolive?
Yann Cotte is listed as CEO at Nanolive.
Where is Nanolive headquartered?
Nanolive is based in Ecublens, Vaud, Switzerland.
How many employees does Nanolive have?
Nanolive is in the 51-100 employee band.
How does Nanolive's funding compare to other Biotechnology startups?
Nanolive's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Nanolive Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nanolive is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.